Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
68,789,466
-
Share change
-
+6,214,605
-
Total reported value
-
$423,701,864
-
Put/Call ratio
-
51%
-
Price per share
-
$6.16
-
Number of holders
-
118
-
Value change
-
+$38,729,544
-
Number of buys
-
56
-
Number of sells
-
45
Institutional Holders of KERYX BIOPHARMACEUTICALS - COMMON STOCK (KERX) as of Q1 2017
As of 31 Mar 2017,
KERYX BIOPHARMACEUTICALS - COMMON STOCK (KERX) was held by
118 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
68,789,466 shares.
The largest 10 holders included
BAUPOST GROUP LLC/MA, VANGUARD GROUP INC, ABRAMS CAPITAL MANAGEMENT, L.P., BlackRock Inc., STATE STREET CORP, FMR LLC, NORGES BANK, AMERIPRISE FINANCIAL INC, RICE HALL JAMES & ASSOCIATES, LLC, and CLEARBRIDGE, LLC.
This page lists
118
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.